References
- 1. Li M, Qu YZ, Zhao ZW, Wu SX, Liu YY, Wei XY, et al. Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules. Neurochem Int. 2012; 60:458-65.10.1016/j.neuint.2012.01.026
- 2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012; 125: e2-e220.
- 3. Datta A, Jingru Q, Khor TH, Teo MT, Heese K, Sze SK. Quantitative neuroproteomics of an in vivo rodent model of focal cerebral ischemia/reperfusion injury reveals a temporal regulation of novel pathophysiological molecular markers. J Proteome Res. 2011; 10: 5199-213.10.1021/pr200673y
- 4. Wang Y, Liao X, Zhao X, Wang DZ, Wang C, Nguyen-Huynh MN, et al. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke. 2011; 42: 1658-64.10.1161/STROKEAHA.110.604249
- 5. Tsubota H, Marui A, Esaki J, Bir SC, Ikeda T, Sakata R. Remote postconditioning may attenuate ischaemia- reperfusion injury in the murine hindlimb through adenosine receptor activation. Eur J Vasc Endovasc Surg. 2010; 40:804-9.10.1016/j.ejvs.2010.08.014
- 6. Kago T, Takagi N, Date I, Takenaga Y, Takagi K, Takeo S. Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries. Biochem Biophys Res Commun. 2006; 339:1197-203.
- 7. Jiao H, Wang Z, Liu Y, Wang P, Xue Y. Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. J Mol Neurosci. 2011; 44:130-9.10.1007/s12031-011-9496-4
- 8. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke. 1998; 29:2189-95.10.1161/01.STR.29.10.2189
- 9. Fukuda S, Fini CA, Mabuchi T, Koziol JA, Eggleston LL Jr, del Zoppo GJ. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke. 2004; 35:998-1004.10.1161/01.STR.0000119383.76447.05
- 10. Bauer AT, B ⃞rgers HF, Rabie T, Marti HH. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab. 2010; 30: 837-48.
- 11. Dejonckheere E, Vandenbroucke RE, Libert C. Matrix metalloproteinases as drug targets in ischemia/ reperfusion injury. Drug Discov Today. 2011; 16: 762-78.
- 12. Pascual O, Casper KB, Kubera C, Zhang J, Revilla- Sanchez R, Sul JY, et al. Astrocytic purinergic signaling coordinates synaptic networks. Science. 2005; 310: 113-6.
- 13. Wang W, Redecker C, Yu ZY, Xie MJ, Tian DS, Zhang L, et al. Rat focal cerebral ischemia induced astrocyte proliferation and delayed neuronal death are attenuated by cyclin-dependent kinase inhibition. J Clin Neurosci. 2008; 15:278-85.10.1016/j.jocn.2007.02.004
- 14. Gursoy-Ozdemir Y, Bolay H, Sariba_ O, Dalkara T. Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia. Stroke. 2000; 31:1974-80; discussion 1981.10.1161/01.STR.31.8.1974
- 15. Gursoy-Ozdemir Y, Can A, Dalkara T. Reperfusioninduced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke. 2004; 35: 1449-53.10.1161/01.STR.0000126044.83777.f4
- 16. Gu Y, Zheng G, Xu M, Li Y, Chen X, Zhu W, et al. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem. 2012; 120:147-56.10.1111/j.1471-4159.2011.07542.x
- 17. Stevanovic ID, Jovanovic MD, Colic M, Jelenkovic A, Bokonjic D, Ninkovic M, et al. N-nitro-L-arginine methyl ester influence on aluminium toxicity in the brain. Folia Neuropathol. 2011; 49:219-29.
- 18. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20:84-91.10.1161/01.STR.20.1.84
- 19. Vakili A, Kataoka H, Plesnila N. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2005; 25:1012-9.
- 20. Belayev L, Busto R, Zhao W, Ginsberg MD. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 1996; 739:88-96.
- 21. Yu F, Kamada H, Niizuma K, Endo H, Chan PH. Induction of MMP-9 expression and endothelial injury by oxidative stress after spinal cord injury. J Neurotrauma. 2008; 25:184-95.10.1089/neu.2007.0438
- 22. Date I, Takagi N, Takagi K, Tanonaka K, Funakoshi H, Matsumoto K, et al. Hepatocyte growth factor attenuates cerebral ischemia- induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels. Neurosci Lett. 2006; 407:141-5.
- 23. Qu YZ, Li M, Zhao YL, Zhao ZW, Wei XY, Liu JP, et al. Astragaloside IV attenuates cerebral ischemia- reperfusion-induced increase in permeability of the blood-brain barrier in rats. Eur J Pharmacol. 2009; 606: 137-41.
- 24. Jung JE, Kim GS, Chen H, Maier CM, Narasimhan P, Song YS, et al. Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol. 2010; 41:172-9.10.1007/s12035-010-8102-z
- 25. Glaser N. Cerebral injury and cerebral edema in children with diabetic ketoacidosis: could cerebral ischemia and reperfusion injury be involved? Pediatr Diabetes. 2009; 10:534-41.10.1111/j.1399-5448.2009.00511.x
- 26. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004; 16:1-13.10.1016/j.nbd.2003.12.016
- 27. Dohgu S, Takata F, Yamauchi A, Nakagawa S, Egawa T, Naito M, et al. Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor- â production. Brain Res. 2005; 1038:208-15.
- 28. Pun PB, Lu J, Moochhala S. Involvement of ROS in BBB dysfunction. Free Radic Res. 2009; 43:348-64.
- 29. Zan L, Wu H, Jiang J, Zhao S, Song Y, Teng G, et al. Temporal profile of Src, SSeCKS, and angiogenic factors after focal cerebral ischemia: correlations with angiogenesis and cerebral edema. Neurochem Int. 2011; 58:872-9.10.1016/j.neuint.2011.02.014
- 30. Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, Watson DJ, et al. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci. 2010; 13:584-91.10.1038/nn.2535
- 31. Cheung WM, Wang CK, Kuo JS, Lin TN. Changes in the level of glial fibrillary acidic protein (GFAP) after mild and severe focal cerebral ischemia. Chin J Physiol. 1999; 42:227-35.
- 32. Pfefferkorn T, Rosenberg GA. Closure of the bloodbrain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke. 2003; 34: 2025-30.10.1161/01.STR.0000083051.93319.28
- 33. Horstmann S, Kalb P, Koziol J, Gardner H, Wagner S. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke. 2003; 34:2165-70.10.1161/01.STR.0000088062.86084.F2
- 34. Suofu Y, Clark JF, Broderick JP, Kurosawa Y, Wagner KR, Lu A. Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion. Neuroscience. 2012; 212:180-9.
- 35. Ryang Y-M, Dang J, Kipp M, Petersen K-U, Fahlenkamp AV, Gempt J, et al. Solulin reduces infarct volume and regulates gene-expression in transient middle cerebral artery occlusion in rats. BMC Neurosci. 2011; 12:113.10.1186/1471-2202-12-113
- 36. Wu Y, Wang YP, Guo P, Ye XH, Wang J, Yuan SY, et al. A lipoxin A4 analog ameliorates blood-brain barrier dysfunction and reduces MMP-9 expression in a rat model of focal cerebral ischemia-reperfusion injury. J Mol Neurosci. 2012; 46: 483-91.10.1007/s12031-011-9620-5
- 37. Tai S-H, Chen H-Y, Lee E-J, Chen T-Y, Lin H-W, Hung Y-C, et al. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia. J Pineal Res. 2010; 49:332-41.10.1111/j.1600-079X.2010.00797.x
- 38. Wang Z, Xue Y, Jiao H, Liu Y, Wang P. Doxycyclinemediated protective effect against focal cerebral ischemia-reperfusion injury through the modulation of tight junctions and PKCä signaling in rats. J Mol Neurosci. 2012; 47:89-100. 10.1007/s12031-011-9689-x